<p>联合健康集团 (NYSE:UNH - 获取免费报告) 在周二向客户和投资者发布的研究报告中，巴克莱的研究分析师将其目标价格从 350.00 美元下调至 300.00 美元，Benzinga 报道。该经纪公司目前对这家医疗保健综合体的股票给予 “中性” 评级。巴克莱的目标价格表明，相较于该股票的前一交易日收盘价，存在 13.43% 的潜在上涨空间。</p>
<p>获取 <strong>联合健康集团</strong> 的提醒：</p>
<ul>
<li>HCA Healthcare 能否振兴市场最疲软的行业？</li>
</ul>
<p>其他几家经纪公司最近也对 UNH 发表了看法。汇丰银行在 5 月 21 日的报告中重申了 “减持” 评级，并将联合健康集团的目标价格设定为 270.00 美元（从 490.00 美元下调）。贝尔德 R W 在 6 月 11 日的报告中将联合健康集团的评级从 “强力买入” 下调至 “持有”。KeyCorp 在 6 月 2 日的研究报告中将联合健康集团的目标价格从 450.00 美元下调至 400.00 美元，并对该公司给予 “增持” 评级。瑞银集团在 7 月 17 日的研究报告中重申了对联合健康集团股票的 “买入” 评级。最后，巴克莱在 7 月 17 日的研究报告中重申了对联合健康集团股票的 “增持” 评级。一位研究分析师对该股票给予了卖出评级，九位给予了持有评级，十五位给予了买入评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “适度买入”，平均目标价格为 389.90 美元。</p>
<p><strong>查看我们对联合健康集团的最新分析</strong></p>
<h2>联合健康集团股票表现</h2>
<ul>
<li>医疗保健股票估值触底，3 只股票有望反弹</li>
</ul>
<p>周二中午交易时，NYSE UNH 的股票下跌了 17.63 美元，跌至 264.49 美元。该公司的交易量为 30,765,320 股，而其平均交易量为 11,523,021 股。该公司的市值为 2399.3 亿美元，市盈率为 11.06，市盈增长比率为 1.39，贝塔值为 0.45。联合健康集团的 1 年最低价为 248.88 美元，1 年最高价为 630.73 美元。该公司的流动比率为 0.85，速动比率为 0.85，债务股本比率为 0.71。该股票的 50 日移动平均价格为 300.91 美元，200 日移动平均价格为 422.56 美元。</p>
<p>联合健康集团 (NYSE:UNH - 获取免费报告) 最近一次发布财报是在 7 月 29 日。该医疗保健综合体报告本季度每股收益为 4.08 美元，低于市场共识预期的 5.16 美元，差额为 1.08 美元。联合健康集团的股本回报率为 26.29%，净利润率为 5.39%。该公司的收入较去年同期增长了 12.9%。在去年同期，该公司每股收益为 6.80 美元。卖方分析师平均预测联合健康集团在本年度的每股收益将达到 29.54 美元。</p>
<h2>联合健康集团内部活动</h2>
<ul>
<li>内部人士在过去两个月内对这 3 只股票进行了数百万美元的投资</li>
</ul>
<p>在其他联合健康集团的新闻中，董事克里斯滕·吉尔在 5 月 15 日的交易中购买了 3,700 股该公司的股票。每股购买价格为 271.17 美元，总价值为 1,003,329.00 美元。完成购买后，该董事在公司中持有 3,818 股，价值为 1,035,327.06 美元。这代表着其持股比例增加了 3,135.59%。该购买在 SEC 的法律文件中披露，相关信息可在 SEC 网站上找到。此外，首席财务官约翰·F·雷克斯在 5 月 16 日的交易中购买了 17,175 股该公司的股票。每股购买成本为 291.12 美元，总交易额为 4,999,986.00 美元。完成购买后，首席财务官持有 203,796 股公司股票，价值约为 59,329,091.52 美元。该交易使其持股比例增加了 9.20%。该购买的披露信息可以在此找到。内部人士在过去 90 天内共购买了 109,408 股公司股票，价值为 31,607,768 美元。公司内部人士目前持有 0.28% 的股票。</p>
<h2>机构资金流入和流出</h2>
<p>对该公司的对冲基金最近调整了持股。先锋集团在第一季度将其在联合健康集团的持股增加了 6.6%。先锋集团目前拥有 90,729,585 股该医疗保健综合体的股票，价值为 47,519,620,000 美元，在此期间又购买了 5,583,343 股。威灵顿管理集团在第一季度将其在联合健康集团的持股增加了 10.6%。威灵顿管理集团目前拥有 25,847,940 股该医疗保健综合体的股票，价值为 13,537,859,000 美元，在此期间又购买了 2,486,839 股。Geode Capital Management 在第四季度将其在联合健康集团的持股增加了 1.6%。Geode Capital Management 目前拥有 19,956,219 股该医疗保健综合体的股票，价值为 10,068,869,000 美元，在此期间又购买了 319,515 股。资本国际投资者在第四季度将其在联合健康集团的持股增加了 6.2%。资本国际投资者目前拥有 15,616,007 股该医疗保健综合体的股票，价值为 7,899,905,000 美元，在此期间又购买了 906,365 股。最后，北方信托公司在第四季度将其在联合健康集团的持股增加了 12.5%。北方信托公司目前拥有 9,503,671 股该医疗保健综合体的股票，价值为 4,807,527,000 美元，在上个季度又购买了 1,058,488 股。机构投资者持有该公司 87.86% 的股票。</p>
<h2>联合健康集团公司简介</h2>
<p>(获取免费报告)</p>
<p>联合健康集团在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：联合健康保险、Optum Health、Optum Insight 和 Optum Rx。联合健康保险部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务，以满足他们的需求；医疗补助计划、儿童健康保险和医疗保健项目；以及健康和牙科福利、医院和临床服务，以及为照顾经济困难、医疗服务不足和没有雇主资助医疗保险覆盖的人群的州项目提供的医疗保健福利产品和服务。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比联合健康集团更好的股票</li>
<li>成长股：它们是什么，它们又不是什么</li>
<li>快速行动：这三只被低估的股票不会长时间保持低位</li>
<li>什么是特别股息？</li>
<li>美国最受欢迎的 220 家本地企业 [2025 年调查]</li>
<li>内部购买解释：投资者需要知道的事项</li>
<li>HCA 医疗保健能否复兴市场上最疲弱的行业？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在联合健康集团吗？</h2>
<p>在考虑联合健康集团之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而联合健康集团并不在名单上。</p>
<p>虽然联合健康集团目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

联合健康

<p>美国银行已将联合健康集团（NYSE:UNH）的目标股价从 350.00 美元下调至 300.00 美元，维持 “中性” 评级。这表明该股票相较于之前的收盘价有 13.43% 的潜在上涨空间。其他券商也调整了他们的评级，汇丰银行设定的目标为 270.00 美元，而贝尔德则下调至 “持有”。联合健康的股票交易价格下跌至 264.49 美元，市值为 2399.3 亿美元，市盈率为 11.06。内部人士最近购买了股票，显示出对公司的信心</p>

<p>UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target reduced by research analysts at Bank of America from $350.00 to $300.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a &#34;neutral&#34; rating on the healthcare conglomerate's stock. Bank of America's price target indicates a potential upside of 13.43% from the stock's previous close.</p>
<div class="lb-trans"><p>联合健康集团 (NYSE:UNH - 获取免费报告) 在周二向客户和投资者发布的研究报告中，巴克莱的研究分析师将其目标价格从 350.00 美元下调至 300.00 美元，Benzinga 报道。该经纪公司目前对这家医疗保健综合体的股票给予 “中性” 评级。巴克莱的目标价格表明，相较于该股票的前一交易日收盘价，存在 13.43% 的潜在上涨空间。</p>
</div><p>Get <strong>UnitedHealth Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>联合健康集团</strong> 的提醒：</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare 能否振兴市场最疲软的行业？</li>
</ul>
</div><p>Several other brokerages have also recently weighed in on UNH. HSBC restated a &#34;reduce&#34; rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Baird R W cut UnitedHealth Group from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Wednesday, June 11th. KeyCorp decreased their target price on UnitedHealth Group from $450.00 to $400.00 and set an &#34;overweight&#34; rating for the company in a research report on Monday, June 2nd. UBS Group reiterated a &#34;buy&#34; rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Barclays reiterated an &#34;overweight&#34; rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of &#34;Moderate Buy&#34; and an average target price of $389.90.</p>
<div class="lb-trans"><p>其他几家经纪公司最近也对 UNH 发表了看法。汇丰银行在 5 月 21 日的报告中重申了 “减持” 评级，并将联合健康集团的目标价格设定为 270.00 美元（从 490.00 美元下调）。贝尔德 R W 在 6 月 11 日的报告中将联合健康集团的评级从 “强力买入” 下调至 “持有”。KeyCorp 在 6 月 2 日的研究报告中将联合健康集团的目标价格从 450.00 美元下调至 400.00 美元，并对该公司给予 “增持” 评级。瑞银集团在 7 月 17 日的研究报告中重申了对联合健康集团股票的 “买入” 评级。最后，巴克莱在 7 月 17 日的研究报告中重申了对联合健康集团股票的 “增持” 评级。一位研究分析师对该股票给予了卖出评级，九位给予了持有评级，十五位给予了买入评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “适度买入”，平均目标价格为 389.90 美元。</p>
</div><p><strong>View Our Latest Analysis on UnitedHealth Group</strong></p>
<div class="lb-trans"><p><strong>查看我们对联合健康集团的最新分析</strong></p>
</div><h2>UnitedHealth Group Stock Performance</h2>
<div class="lb-trans"><h2>联合健康集团股票表现</h2>
</div><ul>
<li>Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗保健股票估值触底，3 只股票有望反弹</li>
</ul>
</div><p>Shares of NYSE UNH traded down $17.63 during mid-day trading on Tuesday, hitting $264.49. The company had a trading volume of 30,765,320 shares, compared to its average volume of 11,523,021. The company has a market capitalization of $239.93 billion, a price-to-earnings ratio of 11.06, a P/E/G ratio of 1.39 and a beta of 0.45. UnitedHealth Group has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock's 50-day moving average price is $300.91 and its 200-day moving average price is $422.56.</p>
<div class="lb-trans"><p>周二中午交易时，NYSE UNH 的股票下跌了 17.63 美元，跌至 264.49 美元。该公司的交易量为 30,765,320 股，而其平均交易量为 11,523,021 股。该公司的市值为 2399.3 亿美元，市盈率为 11.06，市盈增长比率为 1.39，贝塔值为 0.45。联合健康集团的 1 年最低价为 248.88 美元，1 年最高价为 630.73 美元。该公司的流动比率为 0.85，速动比率为 0.85，债务股本比率为 0.71。该股票的 50 日移动平均价格为 300.91 美元，200 日移动平均价格为 422.56 美元。</p>
</div><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $5.16 by ($1.08). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm's revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.80 EPS. On average, sell-side analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current year.</p>
<div class="lb-trans"><p>联合健康集团 (NYSE:UNH - 获取免费报告) 最近一次发布财报是在 7 月 29 日。该医疗保健综合体报告本季度每股收益为 4.08 美元，低于市场共识预期的 5.16 美元，差额为 1.08 美元。联合健康集团的股本回报率为 26.29%，净利润率为 5.39%。该公司的收入较去年同期增长了 12.9%。在去年同期，该公司每股收益为 6.80 美元。卖方分析师平均预测联合健康集团在本年度的每股收益将达到 29.54 美元。</p>
</div><h2>Insider Activity at UnitedHealth Group</h2>
<div class="lb-trans"><h2>联合健康集团内部活动</h2>
</div><ul>
<li>Insiders Spent Millions on These 3 Stocks Over the Past 2 Months</li>
</ul>
<div class="lb-trans"><ul>
<li>内部人士在过去两个月内对这 3 只股票进行了数百万美元的投资</li>
</ul>
</div><p>In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the business's stock in a transaction dated Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director owned 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the purchase, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.28% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他联合健康集团的新闻中，董事克里斯滕·吉尔在 5 月 15 日的交易中购买了 3,700 股该公司的股票。每股购买价格为 271.17 美元，总价值为 1,003,329.00 美元。完成购买后，该董事在公司中持有 3,818 股，价值为 1,035,327.06 美元。这代表着其持股比例增加了 3,135.59%。该购买在 SEC 的法律文件中披露，相关信息可在 SEC 网站上找到。此外，首席财务官约翰·F·雷克斯在 5 月 16 日的交易中购买了 17,175 股该公司的股票。每股购买成本为 291.12 美元，总交易额为 4,999,986.00 美元。完成购买后，首席财务官持有 203,796 股公司股票，价值约为 59,329,091.52 美元。该交易使其持股比例增加了 9.20%。该购买的披露信息可以在此找到。内部人士在过去 90 天内共购买了 109,408 股公司股票，价值为 31,607,768 美元。公司内部人士目前持有 0.28% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its holdings in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP boosted its holdings in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Geode Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the period. Capital International Investors lifted its holdings in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after buying an additional 906,365 shares during the period. Finally, Northern Trust Corp raised its position in shares of UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares in the last quarter. Institutional investors own 87.86% of the company's stock.</p>
<div class="lb-trans"><p>对该公司的对冲基金最近调整了持股。先锋集团在第一季度将其在联合健康集团的持股增加了 6.6%。先锋集团目前拥有 90,729,585 股该医疗保健综合体的股票，价值为 47,519,620,000 美元，在此期间又购买了 5,583,343 股。威灵顿管理集团在第一季度将其在联合健康集团的持股增加了 10.6%。威灵顿管理集团目前拥有 25,847,940 股该医疗保健综合体的股票，价值为 13,537,859,000 美元，在此期间又购买了 2,486,839 股。Geode Capital Management 在第四季度将其在联合健康集团的持股增加了 1.6%。Geode Capital Management 目前拥有 19,956,219 股该医疗保健综合体的股票，价值为 10,068,869,000 美元，在此期间又购买了 319,515 股。资本国际投资者在第四季度将其在联合健康集团的持股增加了 6.2%。资本国际投资者目前拥有 15,616,007 股该医疗保健综合体的股票，价值为 7,899,905,000 美元，在此期间又购买了 906,365 股。最后，北方信托公司在第四季度将其在联合健康集团的持股增加了 12.5%。北方信托公司目前拥有 9,503,671 股该医疗保健综合体的股票，价值为 4,807,527,000 美元，在上个季度又购买了 1,058,488 股。机构投资者持有该公司 87.86% 的股票。</p>
</div><h2>UnitedHealth Group Company Profile</h2>
<div class="lb-trans"><h2>联合健康集团公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p>
<div class="lb-trans"><p>联合健康集团在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：联合健康保险、Optum Health、Optum Insight 和 Optum Rx。联合健康保险部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务，以满足他们的需求；医疗补助计划、儿童健康保险和医疗保健项目；以及健康和牙科福利、医院和临床服务，以及为照顾经济困难、医疗服务不足和没有雇主资助医疗保险覆盖的人群的州项目提供的医疗保健福利产品和服务。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than UnitedHealth Group</li>
<li>Growth Stocks: What They Are, What They Are Not</li>
<li>Act Fast: These 3 Undervalued Stocks Won’t Stay Low for Long</li>
<li>What is a Special Dividend?</li>
<li>Top 220 Most Beloved Local Businesses Across the U.S. [2025 Survey]</li>
<li>Insider Buying Explained: What Investors Need to Know</li>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比联合健康集团更好的股票</li>
<li>成长股：它们是什么，它们又不是什么</li>
<li>快速行动：这三只被低估的股票不会长时间保持低位</li>
<li>什么是特别股息？</li>
<li>美国最受欢迎的 220 家本地企业 [2025 年调查]</li>
<li>内部购买解释：投资者需要知道的事项</li>
<li>HCA 医疗保健能否复兴市场上最疲弱的行业？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=UNH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在联合健康集团吗？</h2>
</div><p>Before you consider UnitedHealth Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑联合健康集团之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而联合健康集团并不在名单上。</p>
</div><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然联合健康集团目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

美国银行将联合健康集团（NYSE:UNH）的目标股价下调至 300 美元